全文获取类型
收费全文 | 142174篇 |
免费 | 10764篇 |
国内免费 | 4068篇 |
专业分类
耳鼻咽喉 | 1044篇 |
儿科学 | 2420篇 |
妇产科学 | 2246篇 |
基础医学 | 8268篇 |
口腔科学 | 3148篇 |
临床医学 | 16823篇 |
内科学 | 21529篇 |
皮肤病学 | 2403篇 |
神经病学 | 7018篇 |
特种医学 | 4494篇 |
外国民族医学 | 43篇 |
外科学 | 17601篇 |
综合类 | 20767篇 |
现状与发展 | 23篇 |
一般理论 | 2篇 |
预防医学 | 5804篇 |
眼科学 | 2108篇 |
药学 | 11329篇 |
86篇 | |
中国医学 | 11369篇 |
肿瘤学 | 18481篇 |
出版年
2024年 | 268篇 |
2023年 | 2420篇 |
2022年 | 4644篇 |
2021年 | 6352篇 |
2020年 | 6074篇 |
2019年 | 5436篇 |
2018年 | 5131篇 |
2017年 | 5419篇 |
2016年 | 5711篇 |
2015年 | 5518篇 |
2014年 | 10193篇 |
2013年 | 12553篇 |
2012年 | 8208篇 |
2011年 | 8829篇 |
2010年 | 7354篇 |
2009年 | 6776篇 |
2008年 | 6635篇 |
2007年 | 6981篇 |
2006年 | 6296篇 |
2005年 | 5599篇 |
2004年 | 4592篇 |
2003年 | 4092篇 |
2002年 | 3354篇 |
2001年 | 2928篇 |
2000年 | 2421篇 |
1999年 | 1887篇 |
1998年 | 1611篇 |
1997年 | 1379篇 |
1996年 | 1142篇 |
1995年 | 1023篇 |
1994年 | 816篇 |
1993年 | 642篇 |
1992年 | 570篇 |
1991年 | 501篇 |
1990年 | 440篇 |
1989年 | 382篇 |
1988年 | 383篇 |
1987年 | 342篇 |
1986年 | 275篇 |
1985年 | 329篇 |
1984年 | 270篇 |
1983年 | 203篇 |
1982年 | 204篇 |
1981年 | 208篇 |
1980年 | 168篇 |
1979年 | 144篇 |
1978年 | 83篇 |
1977年 | 56篇 |
1976年 | 56篇 |
1975年 | 43篇 |
排序方式: 共有10000条查询结果,搜索用时 156 毫秒
991.
Okamura A Yazawa S Nishimura T Tanaka S Takai I Kudo S Asao T Kuwano H Matta KL Akamatsu S Kochibe N 《Clinical & experimental metastasis》2000,18(1):37-43
A new ex vivo method for assaying adhesion of cancer cells to the greater omentum has been developed using mouse greater omentum and [3H]labelled human gastric and mouse colorectal cancer cells. Since the adhesion rates were found to increase up to 18 h and labelled cells seemed to be stable during the period, the present method could be useful for investigating adhesion of cancer cells to the greater omentum, which must occur at the first step of the peritoneal dissemination. The adhesion of cancer cells to the greater omentum was inhibited by a series of chemically synthesized oligosaccharides and Galβ1,3[3OMeGalβ1,4GlcNAcβ1,6]αBn was found to be the best inhibitor. The anti-tumor effect of this novel tetrasaccharide in vivo was shown in preliminary experiments using Balb/c mice and colon26 cells. 相似文献
992.
993.
Whybra C Kampmann C Krummenauer F Ries M Mengel E Miebach E Baehner F Kim K Bajbouj M Schwarting A Gal A Beck M 《Clinical genetics》2004,65(4):299-307
Anderson-Fabry disease (AFD) is an X-linked disorder caused by deficient activity of the lysosomal enzyme alpha-galactosidase A. The availability of enzyme replacement therapy (ERT) for this debilitating condition has led to the need for a convenient and sensitive instrument to monitor clinical effects in an individual patient. This study aimed to develop a scoring system--the Mainz Severity Score Index (MSSI)--to measure the severity of AFD and to monitor the clinical course of the disease in response to ERT. Thirty-nine patients (24 males and 15 females) with AFD were assessed using the MSSI immediately before and 1 year after commencing agalsidase alfa ERT. Control data were obtained from 23 patients in whom AFD was excluded. The MSSI of patients with AFD was significantly higher than that of patients with other severe debilitating diseases. The MSSI indicated that, although more men than women had symptoms classified as severe, overall, the median total severity scores were not significantly different between male and female patients. One year of ERT with agalsidase alfa led, in all patients, to a significant (p < 0.001) reduction in MSSI score (by a median of nine points). This study has shown that the MSSI score may be a useful, specific measure for objectively assessing the severity of AFD and for monitoring ERT-related treatment effects. 相似文献
994.
Wakamatsu T Saito T Hayashi J Takeichi T Kitamoto K Aizawa K 《Medical molecular morphology》2005,38(4):225-232
Flexible treatments for intimal hyperplasia after angioplasty are still needed. The aim of this study was to demonstrate the
long-term effects of vascular photodynamic therapy with talaporfin sodium on intimal hyperplasia following interventional
injury. Intimal hyperplasia was induced by balloon distension injury to the carotid artery in 31 rabbits. Talaporfin, 5.0 mg/kg,
was delivered systemically immediately after balloon injury. The injury site was irradiated with a diode laser light of wavelength
664 nm using a fluence of 50 J/cm2 after 30 min. At day 3 and weeks 3, 6, 9, 15, and 25 after photodynamic therapy, the treated artery of each rabbit was excised
and examined immunohistochemically. Thirty minutes after talaporfin administration, drug fluorescence was found only in the
balloon-injured carotid artery wall. At 3 days, no smooth muscle cells were seen in the media of the photodynamic therapy-treated
arterial segments. Intimal hyperplasia developed progressively in the balloon-injured and untreated segments; however, in
the segments treated with photodynamic therapy, intimal hyperplasia was markedly suppressed until 25 weeks and the media was
repopulated by smooth muscle cells without macrophages. Vascular photodynamic therapy with talaporfin may be used to inhibit
restenosis after vascular intervention.
An erratum to this article is available at . 相似文献
995.
目的探讨阴道镜下高频电灼术联合重组人干扰素α-2a治疗尖锐湿疣(CA)的效果。方法将165例CA分为3组,A组应用阴道镜下高频电灼术联合重组人干扰素α-2a;B组单纯采用阴道镜下高频电灼治疗;C组应用NS-FII型多功能光谱治疗仪联合肌注重组人干扰素α-2a。结果治疗后3-6个月A、B、C组复发率分别为0%、4.4%、65.4%:半年后人乳头瘤病毒(HPV)转阴率分别为93.5%、85.4%、43.8%,A组明显优于B组,B组明显优于C组,3组比较差异有统计学意义(P〈0.01)。结论阴道镜下高频电灼术联合重组人干扰素α-2a治疗CA可明显降低CA复发率和提高HPV转阴率。 相似文献
996.
新兵训练后功能性闭经女兵的心身症状与激素水平 总被引:1,自引:0,他引:1
目的:探讨新人伍女兵功能性下丘脑性闭经(FHA)者与月经正常者激素水平及心理健康状况的差异。方法:在某部队新人伍女兵98人接受了为期近4个月的体能训练之后,有54人出现闭经.其中闭经3个月以上者有35人(研究组)。训练后月经正常、在采血时月经周期处于第5~11天者有26人(对照组)。分别测定她们血清中的促卵泡生成素(FSH)、黄体生成素(LH)、雌二醇(E_2)、孕酮(P)、泌乳素(PRL)、睾酮(T)、ACTH、T_3、T_4的水平,并用SCL-90分别评定她们的心理健康状况。结果:FHA 者血清FSH 值为4.96±1.73 mIU/ml,LH 值为2.63±1.78 mIU/ml,E_2的值为7.23±5.37 pg/ml,对照组血清相应值为10.73±2.30mIU/ml、12.31±2.15mIU/ml、41.67±6.13pg/ml,差异有统计学意义(P<0.01),闭经组低于对照组。FHA 组SCL-90的躯体化、人际敏感、抑郁、焦虑及其他因子分大于2的比率分别为:51.4%、42.9%、48.6%、51.4%及37.1%;而对照组这5项分值大于2的比率分别为15.4%、15.4%、19.2%、21.3%及11.5%,两组间这5个因子大于2的人数差异有统计学显著意义(P<0.05),闭经组高于对照组。结论:诊断为FHA 的女兵与月经正常女兵的激素水平有差异,闭经组心身症状的发生率也高于对照组。 相似文献
997.
从人肝癌组织中提取总RNA,RT—PCR合成hTIMP-1的全长cDNA,克隆到腺病毒载体AdEasy系统的穿梭质粒pAdTraek—CMV上,与骨架质粒pAdEasy-1在BJ5183受体菌中进行同源重组,成功构建含hTIMP-1全长eDNA的重组腺病毒载体,经293细胞的包装、扩增,生成含hTIMP-1基因的重组腺病毒AdhTIMP-1并实现体外表达,为进一步研究肝癌浸润和转移机理以及肝癌的基因治疗提供实验基础。 相似文献
998.
荷EL4肿瘤小鼠模型的建立及美法仑抑瘤作用免疫机制的探讨 总被引:4,自引:6,他引:4
目的:建立荷小鼠淋巴瘤EL4的野生型C57BL/6小鼠及其裸鼠模型,探讨美法仑(melphalan)抑瘤作用的免疫机制。方法:给正常野生型C57BL/6小鼠皮下接种小鼠淋巴瘤EL4细胞,建立荷EL4肿瘤的小鼠模型。于野生型C57BL/6小鼠皮下接种瘤细胞后12d,经腹腔给荷瘤小鼠单次注射不同剂量的美法仑,找出美法仑可发挥最大的抑瘤作用,并能致使肿瘤消退、不再复发的最小使用剂量。然后再给野生型C57BL/6小鼠及其裸鼠(遗传背景相同)皮下同时接种小鼠淋巴瘤EL4细胞建立两种荷瘤小鼠模型。同样于接种瘤细胞后12d,经腹腔给两种荷瘤小鼠模型均注射可使野生型C57BL/6小鼠肿瘤消退、不再复发的最低剂量的美法仑,以正常野生型C57BL/6小鼠为对照,观察在T淋巴细胞缺陷的裸鼠体内美法仑的抑瘤作用。结果:注射7.5mg/kg美法仑治疗后,免疫功能正常的野生型C57BL/6荷瘤小鼠的肿瘤消退;而荷瘤C57BL/6裸鼠的肿瘤仍继续生长。结论:单一剂量的美法仑对荷淋巴瘤EL4小鼠具有明显的治疗作用,其作用的发挥需要T淋巴细胞的参与,可能与T细胞的杀伤作用有关。 相似文献
999.
1000.
Takeshi Komoda MD Thorsten Drews MD Hans B. Lehmkuhl MD Roland Hetzer MD PhD 《Journal of artificial organs》2006,9(1):29-33
The Eurotransplant (ET) allocation algorithm, newly implemented in 2000, gives priority for heart transplantation (HTx) to
patients with high urgency (HU) status, but now this status is rescinded upon ventricular assist device (VAD) implantation
and only regained if severe complications occur during mechanical circulatory support (MCS). We studied the effects of this
change on the patients in our institute who were waiting for HTx with MCS. The median duration of MCS until HTx in adult patients
gradually increased from 3.1 months in 1994, reaching a peak of 16.7 months in 2000, and then gradually decreased to 6.0 months
in 2003. Among the patients with VAD implantation as a bridge to HTx, two patients were on MCS for more than 1 year (the longest
duration of MCS being 1.6 years) at the end of 1999, and this figure increased to nine patients and a maximum MCS duration
of 3.7 years at the end of 2003. These data imply that the patients in whom a complication occurred in the early phase of
MCS and who had overcome this complication underwent HTx early with HU status, and those who were stable during MCS waited
a long time for HTx. Furthermore, the number of patients in the latter group is increasing. The new allocation algorithm imposes
on patients with MCS waiting for HTx who are relatively young and free from complications and serious coexisting disease,
very long-term MCS without an end to VAD bridging, which is almost equivalent to destination therapy.
Part of this paper was presented at the 42nd JSAO Conference (Tokyo, October 5–7, 2004) 相似文献